 | • レポートコード：MRC2110B010 • 出版社/出版日：Persistence Market Research / 2021年9月30日 • レポート形態：英文、PDF、382ページ • 納品方法：Eメール • 産業分類：医療 |
| Individual User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Corporate User | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社の本調査レポートでは、患者エンゲージメントソリューション（PES）の世界市場について調査し、エグゼクティブサマリー、市場概要、市場に影響を与える主要動向、新型コロナウイルス感染症の影響分析、価格分析、市場構造分析、需要分析・予測、市場背景、ソリューション別（ソフトウェア、サービス）分析、展開別（クラウド、オンプレミス）分析、用途別（健康管理、社会的管理、在宅医療管理、財務健康管理、その他）分析、エンドユーザー別（忍耐患者、支払人、医療提供者、その他）分析、地域別分析、競争分析、仮定、調査手法などを掲載しています。 ・エグゼクティブサマリー ・市場概要 ・市場に影響を与える主要動向 ・新型コロナウイルス感染症の影響分析 ・価格分析 ・市場構造分析 ・需要分析・予測 ・市場背景 ・患者エンゲージメントソリューション（PES）の世界市場規模：ソリューション別（ソフトウェア、サービス） ・患者エンゲージメントソリューション（PES）の世界市場規模：展開別（クラウド、オンプレミス） ・患者エンゲージメントソリューション（PES）の世界市場規模：用途別（健康管理、社会的管理、在宅医療管理、財務健康管理、その他） ・患者エンゲージメントソリューション（PES）の世界市場規模：エンドユーザー別（忍耐患者、支払人、医療提供者、その他） ・患者エンゲージメントソリューション（PES）の世界市場規模：地域別 ・競争分析 ・仮定 ・調査手法 |
Patient Engagement Solution Market – Report Scope
The research study on the patient engagement solution market offers a close look at evolving aspects of the market, as well as the dynamics impacting market growth. The research study focuses on key developments that have made their mark in the patient engagement solution market, and other developments that are on the cards. The report talks about various macro- and micro-economic factors responsible for having an in-depth impact on the growth of the market over the forecast period of 2021 to 2031.
A direct market overview provides the growth scenario and market potential with maximum precision, which is adjudged with suitable assumptions. The report features unique and relevant factors that are likely to have a significant impact on the sales of patient engagement solutions during the forecast period. This report includes a detailed and considerable amount of information, which will help new manufacturers and service providers in the most comprehensive manner for better understanding.
Several stakeholders in the market can rely on the data offered in this research study, and delve into pragmatic decision-making. Moreover, information offered in the report also helps new market entrants in expanding their bases in this space.
The report elaborates historical and current trends molding the growth of the patient engagement solution market. The performance journey of the market has been drawn and analyzed in way that the lucrative side is evident to readers. The competitive landscape presented in the report gives a detailed outlook of the profiles of key companies operating in the market, along with their differential strategies and key focus areas.
Market Segmentation
Persistence Market Research’s study on the global patient engagement solution market offers a detailed market segmentation, wherein, key segments have been discussed in detail. The segmentation of the market has been offered on the basis of solution, deployment, application, end user, and region. Every segment has been analyzed in detail, and data pertaining to the growth of each segment has been included in the study.
[Solution]
Solution
Integrated Patient Engagement Software
Standalone Software
Scheduling Software
Billing Software
Secure Messaging Software
Others
Services
Implementation & Integration
Consulting
Support & Maintenance
[Deployment]
Cloud
On-Premise
[Application]
Health Management
Social Management
Home Healthcare Management
Financial Health Management
Others
[End User]
Patients
Payers
Healthcare Providers
Others
[Region]
North America
Latin America
Europe
East Asia
South Asia & Pacific
Middle East & Africa
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Taxonomy
2.2. Market Definition
3. Key Trends Impacting the Market
3.1. Easy and Efficient Access to Patient Engagement Tools and Solutions
3.2. Initiatives for Development of Healthcare Sector from Government
3.3. Other trends
4. COVID-19 Impact Analysis
4.1. Impact of COVID-19 on Patient Engagement Solution Market
4.1.1. Pre COVID-19 Market Growth
4.1.2. Post COVID-19 Market Growth
4.2. Expected Market Recovery Scenario (Short Term/Long Term)
4.3. Key Strategies/Action Points
5. Pricing Analysis
5.1. Pricing Analysis, By Solution
5.2. Average Pricing Benchmark Analysis
6. Market Structure Analysis
6.1. Market Share Analysis, By Key Vendors (Global-level)
6.2. Market Presence Analysis, By Regional Footprint
6.3. Market Positioning by Tier of Vendors (Tier 1/2/3)
7. Global Patient Engagement Solution Market Demand (in Value or Size in US$ Mn) Analysis 2016–2020 and Forecast, 2021–2031
7.1. Historical Market Value (US$ Mn) Analysis, 2016–2020
7.2. Current and Future Market Value (US$ Mn) Projections, 2021–2031
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Market Background
8.1. Macro-Economic Factors
8.2. Forecast Factors – Relevance & Impact
8.3. Value Chain
8.4. Market Dynamics
8.4.1. Drivers
8.4.2. Restraints
8.4.3. Opportunity Analysis
9. Global Patient Engagement Solution Market Analysis 2016–2020 and Forecast 2021–2031, by Solution
9.1. Introduction / Key Findings
9.2. Historical Market Value (US$ Mn Analysis By Solution, 2016–2020
9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Solution, 2021–2031
9.3.1. Software
9.3.1.1. Integrated Patient Engagement Software
9.3.1.2. Standalone Software
9.3.1.2.1. Scheduling Software
9.3.1.2.2. Billing Software
9.3.1.2.3. Secure Messaging Software
9.3.1.2.4. Others
9.3.2. Services
9.3.2.1. Implementation & Integration
9.3.2.2. Consulting
9.3.2.3. Support & Maintenance
9.4. Market Attractiveness Analysis By Solution
10. Global Patient Engagement Solution Market Analysis 2016–2020 and Forecast 2021–2031, by Deployment
10.1. Introduction / Key Findings
10.2. Historical Market Value (US$ Mn) Analysis By Deployment, 2016–2020
10.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Deployment, 2021–2031
10.3.1. Cloud-based
10.3.2. On-premise
10.4. Market Attractiveness Analysis By Deployment
11. Global Patient Engagement Solution Market Analysis 2016–2020 and Forecast 2021–2031, by Application
11.1. Introduction / Key Findings
11.2. Historical Market Value (US$ Mn) Analysis By Application, 2016–2020
11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Application, 2021–2031
11.3.1. Health Management
11.3.2. Social Management
11.3.3. Home Healthcare Management
11.3.4. Financial Health Management
11.3.5. Others
11.4. Market Attractiveness Analysis By Application
12. Global Patient Engagement Solution Market Analysis 2016–2020 and Forecast 2021–2031, by End user
12.1. Introduction / Key Findings
12.2. Historical Market Value (US$ Mn) Analysis By End user, 2016–2020
12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By End user, 2021–2031
12.3.1. Patients
12.3.2. Payers
12.3.3. Healthcare Providers
12.3.4. Others
12.4. Market Attractiveness Analysis By End user
13. Global Patient Engagement Solution Market Analysis 2016–2020 and Forecast 2021–2031, by Region
13.1. Introduction
13.2. Historical Market Value (US$ Mn) Analysis By Region, 2016–2020
13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2021–2031
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. South Asia and Pacific
13.3.5. East Asia
13.3.6. Middle East and Africa
13.4. Market Attractiveness Analysis By Region
14. North America Patient Engagement Solution Market Analysis 2016–2020 and Forecast 2021–2031
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020
14.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031
14.3.1. By Country
14.3.1.1. U.S.
14.3.1.2. Canada
14.3.2. By Solution
14.3.3. By Deployment
14.3.4. By Application
14.3.5. By End user
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Solution
14.4.3. By Deployment
14.4.4. By Application
14.4.5. By End user
14.5. Drivers and Restraints: Impact Analysis
15. Latin America Patient Engagement Solution Market Analysis 2016–2020 and Forecast 2021–2031
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020
15.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Mexico
15.3.1.3. Rest of Latin America
15.3.2. By Solution
15.3.3. By Deployment
15.3.4. By Application
15.3.5. By End user
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Solution
15.4.3. By Deployment
15.4.4. By Application
15.4.5. By End user
15.5. Drivers and Restraints: Impact Analysis
16. Europe Patient Engagement Solution Market Analysis 2016–2020 and Forecast 2021–2031
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020
16.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. Italy
16.3.1.3. France
16.3.1.4. U.K.
16.3.1.5. Spain
16.3.1.6. BENELUX
16.3.1.7. Russia
16.3.1.8. Rest of Europe
16.3.2. By Solution
16.3.3. By Deployment
16.3.4. By Application
16.3.5. By End user
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Solution
16.4.3. By Deployment
16.4.4. By Application
16.4.5. By End user
16.5. Drivers and Restraints: Impact Analysis
17. South Asia and Pacific Patient Engagement Solution Market Analysis 2016–2020 and Forecast 2021–2031
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020
17.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031
17.3.1. By Country
17.3.1.1. India
17.3.1.2. ASEAN
17.3.1.3. Australia and New Zealand
17.3.1.4. Rest of South Asia and Pacific
17.3.2. By Solution
17.3.3. By Deployment
17.3.4. By Application
17.3.5. By End user
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Solution
17.4.3. By Deployment
17.4.4. By Application
17.4.5. By End user
17.5. Drivers and Restraints: Impact Analysis
18. East Asia Patient Engagement Solution Market Analysis 2016–2020 and Forecast 2021–2031
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020
18.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.2. By Solution
18.3.3. By Deployment
18.3.4. By Application
18.3.5. By End user
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Solution
18.4.3. By Deployment
18.4.4. By Application
18.4.5. By End user
18.5. Drivers and Restraints: Impact Analysis
19. Middle East and Africa Patient Engagement Solution Market Analysis 2016–2020 and Forecast 2021–2031
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020
19.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Turkey
19.3.1.3. South Africa
19.3.1.4. Rest of Middle East and Africa
19.3.2. By Solution
19.3.3. By Deployment
19.3.4. By Application
19.3.5. By End user
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Solution
19.4.3. By Deployment
19.4.4. By Application
19.4.5. By End user
19.5. Drivers and Restraints: Impact Analysis
20. Key and Emerging Countries Patient Engagement Solution Market Analysis
20.1. U.S. Patient Engagement Solution Market Opportunity Analysis
20.1.1. By Solution
20.1.2. By Deployment
20.1.3. By Application
20.1.4. By End user
20.2. Canada Patient Engagement Solution Market Opportunity Analysis
20.2.1. By Solution
20.2.2. By Deployment
20.2.3. By Application
20.2.4. By End user
20.3. Mexico Patient Engagement Solution Market Opportunity Analysis
20.3.1. By Solution
20.3.2. By Deployment
20.3.3. By Application
20.3.4. By End user
20.4. Brazil Patient Engagement Solution Market Opportunity Analysis
20.4.1. By Solution
20.4.2. By Deployment
20.4.3. By Application
20.4.4. By End user
20.5. Germany Patient Engagement Solution Market Opportunity Analysis
20.5.1. By Solution
20.5.2. By Deployment
20.5.3. By Application
20.5.4. By End user
20.6. Italy Patient Engagement Solution Market Opportunity Analysis
20.6.1. By Solution
20.6.2. By Deployment
20.6.3. By Application
20.6.4. By End user
20.7. France Patient Engagement Solution Market Opportunity Analysis
20.7.1. By Solution
20.7.2. By Deployment
20.7.3. By Application
20.7.4. By End user
20.8. U.K. Patient Engagement Solution Market Opportunity Analysis
20.8.1. By Solution
20.8.2. By Deployment
20.8.3. By Application
20.8.4. By End user
20.9. Spain Patient Engagement Solution Market Opportunity Analysis
20.9.1. By Solution
20.9.2. By Deployment
20.9.3. By Application
20.9.4. By End user
20.10. BENELUX Patient Engagement Solution Market Opportunity Analysis
20.10.1. By Solution
20.10.2. By Deployment
20.10.3. By Application
20.10.4. By End user
20.11. Russia Patient Engagement Solution Market Opportunity Analysis
20.11.1. By Solution
20.11.2. By Deployment
20.11.3. By Application
20.11.4. By End user
20.12. China Patient Engagement Solution Market Opportunity Analysis
20.12.1. By Solution
20.12.2. By Deployment
20.12.3. By Application
20.12.4. By End user
20.13. Japan Patient Engagement Solution Market Opportunity Analysis
20.13.1. By Solution
20.13.2. By Deployment
20.13.3. By Application
20.13.4. By End user
20.14. S. Korea Patient Engagement Solution Market Opportunity Analysis
20.14.1. By Solution
20.14.2. By Deployment
20.14.3. By Application
20.14.4. By End user
20.15. India Patient Engagement Solution Market Opportunity Analysis
20.15.1. By Solution
20.15.2. By Deployment
20.15.3. By Application
20.15.4. By End user
20.16. ASEAN Patient Engagement Solution Market Opportunity Analysis
20.16.1. By Solution
20.16.2. By Deployment
20.16.3. By Application
20.16.4. By End user
20.17. Australia and New Zealand Patient Engagement Solution Market Opportunity Analysis
20.17.1. By Solution
20.17.2. By Deployment
20.17.3. By Application
20.17.4. By End user
20.18. GCC Countries Patient Engagement Solution Market Opportunity Analysis
20.18.1. By Solution
20.18.2. By Deployment
20.18.3. By Application
20.18.4. By End user
20.19. Turkey Patient Engagement Solution Market Opportunity Analysis
20.19.1. By Solution
20.19.2. By Deployment
20.19.3. By Application
20.19.4. By End user
20.20. South Africa Patient Engagement Solution Market Opportunity Analysis
20.20.1. By Solution
20.20.2. By Deployment
20.20.3. By Application
20.20.4. By End user
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Deep Dive
21.2.1. Allscripts Healthcare Solutions
21.2.1.1. Business Overview
21.2.1.2. Solution Offering
21.2.1.3. Financial Performance
21.2.1.4. Key Strategies
21.2.2. McKesson Corporation
21.2.2.1. Business Overview
21.2.2.2. Solution Offering
21.2.2.3. Financial Performance
21.2.2.4. Key Strategies
21.2.3. Cerner Corporation
21.2.3.1. Business Overview
21.2.3.2. Solution Offering
21.2.3.3. Financial Performance
21.2.3.4. Key Strategies
21.2.4. Phytel Inc
21.2.4.1. Business Overview
21.2.4.2. Solution Offering
21.2.4.3. Financial Performance
21.2.4.4. Key Strategies
21.2.5. Medecision Inc
21.2.5.1. Business Overview
21.2.5.2. Solution Offering
21.2.5.3. Financial Performance
21.2.5.4. Key Strategies
21.2.6. Athenahealth, Inc.
21.2.6.1. Business Overview
21.2.6.2. Solution Offering
21.2.6.3. Financial Performance
21.2.6.4. Key Strategies
21.2.7. Novartis
21.2.7.1. Business Overview
21.2.7.2. Solution Offering
21.2.7.3. Financial Performance
21.2.7.4. Key Strategies
21.2.8. Roche Holding AG
21.2.8.1. Business Overview
21.2.8.2. Solution Offering
21.2.8.3. Financial Performance
21.2.8.4. Key Strategies
21.2.9. Bayer
21.2.9.1. Business Overview
21.2.9.2. Solution Offering
21.2.9.3. Financial Performance
21.2.9.4. Key Strategies
21.2.10. GlaxoSmithKline
21.2.10.1. Business Overview
21.2.10.2. Solution Offering
21.2.10.3. Financial Performance
21.2.10.4. Key Strategies
21.2.11. IQVIA
21.2.11.1. Business Overview
21.2.11.2. Solution Offering
21.2.11.3. Financial Performance
21.2.11.4. Key Strategies
22. Assumptions and Acronyms Used
23. Research Methodology